RYTM
Rhythm Pharmaceuticals Inc
98.30$
+0.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.9% | -98.9% | +19,113.9% | -66.9% | +1,129.7% | +71.5% | +18.6% | -39.4% | +76.1% | +16.1% | -13.0% | +17.9% | +22.4% | |
| – | -3.8% | -98.9% | +18,194.8% | -68.5% | +1,248.3% | +71.7% | +16.9% | -39.9% | +69.8% | +14.9% | -13.0% | +21.4% | +24.8% | |
| – | -37.4% | -97.9% | +22,840.1% | -81.2% | +423.5% | +44.7% | +25.7% | +61.9% | -41.3% | +115.5% | -52.9% | +48.4% | -39.1% | |
| – | +4.3% | -99.1% | +22,840.1% | -69.8% | +1,305.4% | +70.2% | +16.0% | -40.9% | +70.6% | +13.0% | -17.2% | +16.2% | +21.3% | |
| – | – | – | – | – | – | – | – | – | – | +507.2% | +138.9% | +24.5% | +40.9% | |
| – | – | – | – | – | – | – | – | – | – | +2,527.9% | +195.6% | +117.3% | +37.4% | |
| – | – | – | – | +5,370.6% | -9.7% | +33.3% | +410.4% | -44.1% | -12.0% | -21.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +69.2% | -10.8% | -12.2% | -13.8% | |
| – | +37.0% | -99.3% | +855.4% | -4.4% | +37.8% | +100.8% | +97.1% | -25.3% | +120.8% | +160.6% | +37.9% | +39.7% | -7.7% | |
| – | +22.3% | -82.0% | +855.4% | -10.3% | +42.0% | +102.1% | +79.8% | -26.3% | +141.3% | -8.3% | +38.7% | +109.3% | -8.3% | |
| – | – | – | – | – | – | – | – | +13.3% | +13.3% | +12.9% | +12.6% | +100.1% | -57.8% | |
| – | -34.7% | -63.5% | +166.9% | +32.7% | +28.1% | +214.8% | +36.3% | -53.0% | +17.1% | -16.4% | +1.8% | +152.4% | +13.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -77.2% | +1,884.2% | +70.1% | +14.1% | -40.7% | +70.6% | -7.0% | -35.8% | -3.1% | +64.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -79.7% | +0.0% | +64.1% | +59.8% | +16.0% | +17.5% | +21.2% | +12.4% | +5.1% | +10.7% | +5.8% | +6.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.